Cancer Research Technology
Log in Register
Menu

Anti-CD13, Recombinant [22A5]

Info

Catalogue Number 153258
Applications FACS IHC IP
Antigen/Gene or Protein Targets Aminopeptidase N (CD13)
Synonyms Alanyl Aminopeptidase; Membrane; Microsomal Aminopeptidase; Aminopeptidase M; Myeloid Plasma Membrane Glycoprotein CD13; GP150; CD13; PEPN
Reactivity Human
Relevance Aminopeptidase N (CD13) is a cell-surface metalloprotease involved in the metabolism of regulatory peptides. 22A5 may be useful for the diagnosis and immunophenotyping of leukaemia.
Host Mouse
Immunogen A cell suspension containing osteoclasts from osteoclastomas.
Subclass IgG2a kappa
Formulation PBS
Concentration 1mgml-1
Positive Control Cells of myelomonocytic lineage
Research Area Cancer, Immunology, Metabolism
Notes Recombinant monoclonal antibody produced from the original monoclonal cell line. Manufactured using Absolute Antibody’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma.

Six products based on this clone:
- Anti-CD13 [22A5], Mouse IgG2a, Kappa
- Anti-CD13 [22A5], Mouse IgG2a, Kappa, engineered Fc domain containing key point mutations that abrogate binding to Fc gamma receptors
- Anti-CD13 [22A5], Rabbit IgG, Kappa
- Anti-CD13 [22A5], Human IgG4-S228P, Kappa
- Anti-CD13 [22A5], Human IgG1, Kappa
- Anti-CD13 [22A5], Human IgG1, Kappa, engineered Fc domain containing key point mutations that abrogate binding to Fc gamma receptors

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Original hybridoma first published in: Horton et al. 1985. Cancer Res. 45(11 Pt 2):5663-9. PMID: 4053038.


Add a reference

References: 1 entry

Original hybridoma first published in: Horton et al. 1985. Cancer Res. 45(11 Pt 2):5663-9. PMID: 4053038.


Add a reference

Inventor Information